Cyclophosphamide
A nitrogen mustard alkylating agent that cross-links DNA strands to kill rapidly dividing cells, used to treat various cancers including lymphoma, leukemia, and breast cancer, as well as severe autoimmune diseases. It requires activation by liver enzymes and can cause serious side effects including hemorrhagic cystitis.
分子量
261.0800 g/mol
LogP
0.60
TPSA
41.60 Ų
Lipinski 五规则
符合
治疗领域
作用机制
Forms covalent bonds with DNA bases, creating cross-links and strand breaks that prevent DNA replication and transcription. This triggers apoptosis in rapidly dividing cells, particularly cancer cells.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Forms covalent bonds with DNA bases, creating cross-links and strand breaks that prevent DNA replication and transcription. This triggers apoptosis in rapidly dividing cells, particularly cancer cells.
二维结构
Cite this structure
Embed this structure
SMILES
O.O=P1(N(CCCl)CCCl)NCCCO1
InChI
InChI=1S/C7H15Cl2N2O2P.H2O/c8-2-5-11(6-3-9)14(12)10-4-1-7-13-14;/h1-7H2,(H,10,12);1H2
Molecular Formula
C7H15Cl2N2O2P
HBD / HBA
1 / 4
可旋转键数
5
重原子数
14
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
常见问题
A nitrogen mustard alkylating agent that cross-links DNA strands to kill rapidly dividing cells, used to treat various cancers including lymphoma, leukemia, and breast cancer, as well as severe autoimmune diseases. It requires activation by liver enzymes and can cause serious side effects including hemorrhagic cystitis.
Forms covalent bonds with DNA bases, creating cross-links and strand breaks that prevent DNA replication and transcription. This triggers apoptosis in rapidly dividing cells, particularly cancer cells.
Yes, Cyclophosphamide is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200796. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 2907. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="cyclophosphamide"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/cyclophosphamide/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/cyclophosphamide/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/cyclophosphamide/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="cyclophosphamide"></drugfyi-drug>